Skip to main content

Table 3 Relation between SBP measured by different tools monitoring and early hypertensive end organ damage

From: Comparison between central and ambulatory blood pressure measurements in early detection of end organ damage: a single-center prospective non-randomized controlled trial

  ABPM P value Central P value
Controlled Not controlled Controlled Not controlled
No. (%) No. (%) No. (%) No. (%)
ECG
 Normal 48 (96%) 13 (26%) 0.000** 49 (90.7%) 12 (26.1%) 0.000**
 LVH 2 (4%) 34 (68%) 5 (9.3%) 31 (67.4%)
 LBBB 0 (0%) 3 (6%) 0 (0%) 3 (6.5%)
LVMI
 Normal 47 (94%) 37 (74%) 0.006** 52 (96.3%) 32 (69.6%) 0.000**
 Abnormal 3 (6%) 13 (26%) 2 (3.7%) 14 (30.4%)
CIMT
 Normal 47 (94%) 37 (74%) 0.006** 51 (94. 4%) 33 (71.7%) 0.002**
 Abnormal 3 (6%) 13 (26%) 3 (5. 6%) 13 (28.3%)
PWV
 Normal 50 (100%) 43 (86%) 0.006** 54 (100%) 39 (84.8%) 0.003**
 Abnormal 0 (0%) 7 (14%) 0 (0%) 7 (15. 2%)
ABI
 Normal 39 (78%) 21 (42%) 0.000** 41 (75.9%) 19 (41.3%) 0.000**
 Abnormal 11 (22%) 29 (58%) 13 (24.1%) 27 (58.7%)
Creatinine
 Normal 47 (94%) 30 (60%) 0.000** 52 (96.3%) 25 (54.3%) 0.000**
 Abnormal 3 (6%) 20 (40%) 2 (3.7%) 21 (45.7%)
GFR
 Normal 47 (94%) 36 (72%) 0.003** 50 (92.6%) 33 (71.7%) 0.006**
 Abnormal 3 (6%) 14 (28%) 4 (7.4%) 13 (28.3%)
  1. Chi-square test
  2. *Statistically significant difference (p < 0.05)
  3. **Highly statistically significant difference (p < 0.01)
  4. HTN hypertension, ABPM ambulatory blood pressure monitoring, PWV pulse wave velocity, Cr creatinine, GFR glomerular filtration ratio, LVMI left ventricular mass index, CIMT carotid intimal thickness, ABI ankle-brachial index